Opening book details…
About this Medicine article
Phase Ii Study of Carboplatin/Etoposide Plus Ly2510924, a Cxcr4 Peptide Antagonist, Versus Carboplatin/Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer (Sclc) by Spigel, D.R.; Weaver, R.W.; McCleod, M.; Hamid, O.; Stille, J.R.; Polzer, J.; Roberson, S.; Salgia, R. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Spigel, D.R.; Weaver, R.W.; McCleod, M.; Hamid, O.; Stille, J.R.; Polzer, J.; Roberson, S.; Salgia, R.
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2014
- Field
- Medicine (Health Sciences)